OrthoCyte Technology

OrthoCyte Technology. Shall be the technology, including the HyStem® Delivery System, to select, expand, manufacture, combine and use the OrthoCyte Materials, as covered by the Intellectual Property Rights owned by OrthoCyte or BioTime or licensed in from a Third Party, including the University of Utah Research Foundation. The OrthoCyte Technology includes the patent applications and patents identified and listed in Exhibit C.